The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Adegunsoye, Ayodeji
keywords Pulmonary Fibrosis
overview I am a pulmonary & critical care physician-scientist whose interests focus on the intersection between clinical risk-prediction models and genomic markers to improve pulmonary fibrosis outcomes. Pulmonary fibrosis is a destructive interstitial lung disease characterized by profound scarring. In severe pulmonary fibrosis, death generally ensues within three to five years. Recent genomic advances have identified factors that influence heterogeneity and prognosis in pulmonary fibrosis. However, healthcare disparities and the exclusion of major racial groups from these genetic studies limits the generalizability of their findings. My work leverages advanced statistical techniques to improve the delivery of high-quality care in patients with fibrotic lung diseases. Much of my research is aimed at identifying improved practical strategies to optimize pharmacotherapy in patients with pulmonary fibrosis. The main thrust of my work is currently on utilizing genetic data from diverse races to improve clinical decision-making and outcomes for all patients with pulmonary fibrosis.
One or more keywords matched the following items that are connected to Adegunsoye, Ayodeji
Item TypeName
Concept Idiopathic Pulmonary Fibrosis
Academic Article Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.
Academic Article Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.
Academic Article Imaging of Hypersensitivity Pneumonitis.
Academic Article Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.
Academic Article Therapeutic Approach to Adult Fibrotic Lung Diseases.
Academic Article ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.
Academic Article CT findings associated with survival in chronic hypersensitivity pneumonitis.
Academic Article Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.
Academic Article N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.
Academic Article CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines.
Academic Article CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
Academic Article Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
Academic Article Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Academic Article Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.
Academic Article Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
Academic Article Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
Academic Article MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis.
Academic Article Diagnostic Delay in Idiopathic Pulmonary Fibrosis: Where the Rubber Meets the Road.
Grant Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
Academic Article Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
Academic Article Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.
Academic Article Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies.
Academic Article Anticoagulation and Pulmonary Fibrosis: Friends, Foes, or Functional Allies?
Academic Article Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
Academic Article Treatment of fibrotic interstitial lung disease: current approaches and future directions.
Academic Article Hospitalizations in patients with idiopathic pulmonary fibrosis.
Academic Article Lung function trajectory in progressive fibrosing interstitial lung disease.
Academic Article Racial Disparities in Pulmonary Fibrosis and the Impact on the Black Population.
Academic Article Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
Academic Article Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
Academic Article Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
Academic Article Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.
Academic Article Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
Academic Article PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
Academic Article Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults.
Academic Article Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.
Academic Article Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
Academic Article Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
Academic Article Telomere Length and Immunosuppression in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease.
Academic Article Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis.
Academic Article Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States.
Academic Article Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
Academic Article Computer-Aided Pulmonary Fibrosis Detection Leveraging an Advanced Artificial Intelligence Triage and Notification Software.
Academic Article Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection-response to Guangting Zeng and Yuchi Zhou.
Academic Article Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
Academic Article Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.
Search Criteria
  • Pulmonary Fibrosis